Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7756.37% is 143% below its 5-year average of -3194.19%, around the middle of its 5-year range (-13766.98%–-1150.65%).
6.57% above its 12-month average of -8301.51%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -10443.40%.
NET PROFIT MARGIN
-7756.37%
NET PROFIT MARGIN AVG TTM
-8301.51%
NET PROFIT MARGIN AVG 3Y
-5020.53%
NET PROFIT MARGIN AVG 5Y
-3194.19%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+6.57%
CURRENT VS 3Y AVG
-54.49%
CURRENT VS 5Y AVG
-142.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 760 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Absci Corporation
Market Cap
$1.79B
Net Profit Margin
-7756.37%
TTM Avg
-8301.51%
3Y Avg
-5020.53%
5Y Avg
-3194.19%
Market Cap
$1.79B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.80B
Net Profit Margin
0.89%
TTM Avg
-2.38%
3Y Avg
-5.83%
5Y Avg
-7.07%
Market Cap
$1.81B
Net Profit Margin
-21.25%
TTM Avg
-24.32%
3Y Avg
-26.63%
5Y Avg
-18.90%
Market Cap
$1.76B
Net Profit Margin
-2.63%
TTM Avg
-3.88%
3Y Avg
-2.58%
5Y Avg
-3.29%
Market Cap
$1.82B
Net Profit Margin
25.02%
TTM Avg
21.58%
3Y Avg
17.87%
5Y Avg
17.55%
Market Cap
$1.83B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.84B
Net Profit Margin
-59.87%
TTM Avg
5.85%
3Y Avg
-31.86%
5Y Avg
-479.70%
Market Cap
$1.72B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Absci Corporation (ABSI) | $1.79B | -7756.37% | -8301.51% | -5020.53% | -3194.19% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | -636.99% | -743.17% | -743.17% | -743.17% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.80B | 0.89% | -2.38% | -5.83% | -7.07% |
| Novocure Ltd (NVCR)vs › | $1.81B | -21.25% | -24.32% | -26.63% | -18.90% |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | -2.63% | -3.88% | -2.58% | -3.29% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 25.02% | 21.58% | 17.87% | 17.55% |
| Azenta, Inc. (AZTA)vs › | $1.83B | -20.02% | -19.08% | -29.38% | -13.21% |
| Novavax, Inc. (NVAX)vs › | $1.84B | -59.87% | 5.85% | -31.86% | -479.70% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | -14.99% | -20.12% | -16.95% | -10.04% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 1.05% | 1.42% | 2.79% | 2.28% |
Operating Margin
-4454.2%
Net Profit Margin
-7756.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -10443.40% |
| 2026-03-31 | -13766.98% |
| 2025-12-31 | -4548.00% |
| 2025-09-30 | -7594.18% |
| 2025-06-30 | -5154.97% |
| 2025-03-31 | -2234.61% |
| 2024-12-31 | -4358.35% |
| 2024-09-30 | -1610.70% |
| 2024-06-30 | -1948.82% |
| 2024-03-31 | -2447.10% |
| 2023-12-31 | -6965.98% |
| 2023-09-30 | -2956.18% |
| 2023-06-30 | -1237.66% |
| 2023-03-31 | -1840.43% |
| 2022-12-31 | -1250.55% |
| 2022-09-30 | -1150.65% |
| 2022-06-30 | -2862.28% |
| 2022-03-31 | -3601.22% |
| 2021-12-31 | -1733.20% |
| 2021-09-30 | -1535.67% |
| 2021-06-30 | -5659.07% |
| 2021-03-31 | -1031.23% |
| 2020-12-31 | -181.05% |
| 2020-09-30 | -409.17% |
| 2020-06-30 | -533.33% |
| 2020-03-31 | -464.69% |
